High efficacy of adefovir and entecavir combination therapy in patients with nucleoside-refractory hepatitis B

BACKGROUND/AIMS: Newly developed and potent antiviral agents suffer from the problem of drug resistance. Multidrug resistance is a major impediment in the treatment of patients with chronic hepatitis B (CHB). In line with American Association for the Study of Liver Diseases guidelines, adefovir dipi...

Descripción completa

Detalles Bibliográficos
Autores principales: Chae, Hee Bok, Kim, Mee Jin, Seo, Eui Geun, Choi, Yong Hyeok, Lee, Hee Seung, Han, Joung Ho, Yoon, Soon Man, Park, Seon Mee, Youn, Sei Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association for the Study of the Liver 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3326991/
https://www.ncbi.nlm.nih.gov/pubmed/22511906
http://dx.doi.org/10.3350/kjhep.2012.18.1.75

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3326991/
https://www.ncbi.nlm.nih.gov/pubmed/22511906
http://dx.doi.org/10.3350/kjhep.2012.18.1.75

Ejemplares similares